TWI916398B - 含有烷基-氧雜環烷基部分之胺磺醯基脲衍生物及其用途 - Google Patents
含有烷基-氧雜環烷基部分之胺磺醯基脲衍生物及其用途Info
- Publication number
- TWI916398B TWI916398B TW110132880A TW110132880A TWI916398B TW I916398 B TWI916398 B TW I916398B TW 110132880 A TW110132880 A TW 110132880A TW 110132880 A TW110132880 A TW 110132880A TW I916398 B TWI916398 B TW I916398B
- Authority
- TW
- Taiwan
- Prior art keywords
- disease
- compound
- pharmaceutically acceptable
- compounds
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074521P | 2020-09-04 | 2020-09-04 | |
| US63/074,521 | 2020-09-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202229265A TW202229265A (zh) | 2022-08-01 |
| TWI916398B true TWI916398B (zh) | 2026-03-01 |
Family
ID=77951864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110132880A TWI916398B (zh) | 2020-09-04 | 2021-09-03 | 含有烷基-氧雜環烷基部分之胺磺醯基脲衍生物及其用途 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240043410A1 (enExample) |
| EP (1) | EP4208459A1 (enExample) |
| JP (1) | JP7865948B2 (enExample) |
| KR (1) | KR20230061505A (enExample) |
| CN (1) | CN116783184A (enExample) |
| AR (1) | AR123435A1 (enExample) |
| AU (1) | AU2021336518B2 (enExample) |
| BR (1) | BR112023003792A2 (enExample) |
| CA (1) | CA3191410A1 (enExample) |
| IL (1) | IL301055A (enExample) |
| MX (1) | MX2023002686A (enExample) |
| TW (1) | TWI916398B (enExample) |
| WO (1) | WO2022051582A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201721185D0 (en) | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| HUE067378T2 (hu) | 2019-06-12 | 2024-10-28 | Nodthera Ltd | Szulfonilurea származékok és alkalmazásaik |
| JP7661248B2 (ja) | 2019-06-12 | 2025-04-14 | ノッドセラ リミテッド | スルホニル尿素誘導体及びその使用 |
| KR20260115622A (ko) * | 2023-11-17 | 2026-07-24 | 노드테라 리미티드 | 우레아 유도체의 제조 방법 |
| CN122555701A (zh) | 2023-11-17 | 2026-08-11 | 诺瑟拉有限公司 | 脲衍生物的形式和相关用途 |
| TW202545527A (zh) * | 2024-01-16 | 2025-12-01 | 英商諾得瑟拉公司 | Nlrp3及glp-1a組合療法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019121691A1 (en) | 2017-12-18 | 2019-06-27 | NodThera Limited | Sulphonyl urea derivatives as nlrp3 inflammasome modulators |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| DK1270565T3 (da) | 1997-01-29 | 2004-10-04 | Pfizer | 4-substitueret furan-2-sulfonamid og dets anvendelse i fremstillingen af sulfonylurinstofderivater |
| JP6929792B2 (ja) * | 2015-02-16 | 2021-09-01 | ザ ユニバーシティ オブ クィーンズランド | スルホニル尿素及び関連化合物並びにその使用 |
| JP7412328B2 (ja) | 2017-07-24 | 2024-01-12 | ノバルティス アーゲー | Nlrp活性に関連する状態を治療するための化合物及び組成物 |
| SG11202101480XA (en) | 2018-08-15 | 2021-03-30 | Inflazome Ltd | Novel sulfonamideurea compounds |
-
2021
- 2021-09-03 JP JP2023514910A patent/JP7865948B2/ja active Active
- 2021-09-03 EP EP21778667.2A patent/EP4208459A1/en active Pending
- 2021-09-03 MX MX2023002686A patent/MX2023002686A/es unknown
- 2021-09-03 WO PCT/US2021/049001 patent/WO2022051582A1/en not_active Ceased
- 2021-09-03 CA CA3191410A patent/CA3191410A1/en active Pending
- 2021-09-03 CN CN202180074301.7A patent/CN116783184A/zh active Pending
- 2021-09-03 KR KR1020237011396A patent/KR20230061505A/ko active Pending
- 2021-09-03 AU AU2021336518A patent/AU2021336518B2/en active Active
- 2021-09-03 US US18/043,883 patent/US20240043410A1/en active Pending
- 2021-09-03 AR ARP210102472A patent/AR123435A1/es unknown
- 2021-09-03 IL IL301055A patent/IL301055A/en unknown
- 2021-09-03 TW TW110132880A patent/TWI916398B/zh active
- 2021-09-03 BR BR112023003792A patent/BR112023003792A2/pt unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019121691A1 (en) | 2017-12-18 | 2019-06-27 | NodThera Limited | Sulphonyl urea derivatives as nlrp3 inflammasome modulators |
Also Published As
| Publication number | Publication date |
|---|---|
| IL301055A (en) | 2023-05-01 |
| CA3191410A1 (en) | 2022-03-10 |
| BR112023003792A2 (pt) | 2023-03-28 |
| AU2021336518A1 (en) | 2023-03-23 |
| EP4208459A1 (en) | 2023-07-12 |
| AU2021336518B2 (en) | 2026-05-21 |
| MX2023002686A (es) | 2023-04-03 |
| AR123435A1 (es) | 2022-11-30 |
| JP2023540733A (ja) | 2023-09-26 |
| US20240043410A1 (en) | 2024-02-08 |
| KR20230061505A (ko) | 2023-05-08 |
| JP7865948B2 (ja) | 2026-05-26 |
| WO2022051582A1 (en) | 2022-03-10 |
| TW202229265A (zh) | 2022-08-01 |
| CN116783184A (zh) | 2023-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7339959B2 (ja) | Nlrp3インフラマソーム調節剤としてのスルホニル尿素誘導体 | |
| US12227488B2 (en) | Small molecule degraders of Helios and methods of use | |
| TWI810198B (zh) | Nlrp3發炎體之選擇性抑制劑 | |
| TW202229265A (zh) | 含有烷基-氧雜環烷基部分之胺磺醯基脲衍生物及其用途 | |
| JP2020533288A (ja) | Enpp1阻害剤及びがんの治療のためのそれらの使用 | |
| JP7661248B2 (ja) | スルホニル尿素誘導体及びその使用 | |
| WO2023221975A1 (zh) | 包含蛋白降解剂类生物活性化合物的抗体药物偶联物及其制备方法和用途 | |
| JP7682813B2 (ja) | スルホニル尿素誘導体及びその使用 | |
| JP2022535955A (ja) | スルホンアミド誘導体及びその使用 | |
| KR20240145992A (ko) | 비사이클릭 프탈라진-1(2h)-온 유도체 및 관련 용도 | |
| JP2022518526A (ja) | カルバメート誘導体およびその使用 | |
| WO2024027795A1 (zh) | 包含Myc蛋白降解剂类生物活性化合物的抗体药物偶联物及其制备方法和用途 | |
| RU2858266C2 (ru) | Производные сульфамоилмочевины, содержащие алкилоксациклоалкильную группу, и их применения |